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DIFFERENTIAL EFFECTS OF REDUCED FOOT SOLE SENSITIVITY AND NERVE 
CONDUCTION VELOCITY ON POSTURAL CONTROL AND FUNCTIONAL GAIT 
by 
KELSEY LEWIS 
Under the Direction of Li Li 
ABSTRACT  
INTRODUCTION: Peripheral neuropathy is characterized by a loss of foot sole sensitivity and slowed 
nerve conduction velocity. Individuals with peripheral neuropathy have decreased postural control ability 
and functional gait performance. No research was found that differentiated the effects of the main 
symptoms of peripheral neuropathy on postural control and functional gait. PURPOSE: The purpose of 
this study was to assess the differential effects of reduced foot sole sensitivity and slowed nerve 
conduction velocity on postural control and functional gait. METHODS: Two main clinical symptoms, H-
index and foot sole sensitivity were evaluated among 35 participants. Outcome variables are the center of 
pressure standard deviation in the anteroposterior direction (SDAP) and the center of pressure average 
velocity (Vavg) during 30 seconds eyes open quiet standing, 6-minute walk distance (6MWD), and timed-
up-and-go duration (TUG). RESULTS: Participants were separated into three groups symptomologically: 
Less affected (LA, 73±2 years old, 68.4±3.5kg, 1.62±0.02m, H-index: 89.7±3.4, range 78.0-109.4, 
cm2/ms2, Foot sole sensitivity score: 8.6±0.5, range 6-10), moderately affected (MA, 74±2 years old, 
77.2±4.1kg, 1.65±0.02m, H-index: 60.2±3.4, range 42.8-76-6, cm2/ms2, Foot sole sensitivity score: 
8.7±0.5, range 6-10), and severely affected (SA, 73±1 years old, 95.2±6.5kg, 1.73±0.03m, H-index: 
61.8±2.1, range 45.6-75.5, cm2/ms2, Foot sole sensitivity score: 2.2±0.6, range 0-5). Multivariate analysis 
revealed significant group differences (p<.05), where post-hoc showed significant differences between 
LA and SA in Vavg (F4,30=3.752, p=0.014). A discriminant analysis revealed that Vavg was the primary 
determinant and 6MWD and TUG were secondary determinents to the separation between the groups. 
Further analysis demonstrated that the severity of the disease mediates the relationship between the 
clinical symptoms and functional performance. The affect of foot sole sensitivity on functional 
 
performance was very different for people within the LA and MA group. People in the MA group had 
much lower H-index values indicating slower nerve conduction velocity even though foot sole sensitivity 
of both groups was within the same range. On the other hand, the affect of nerve conduction velocity, 
measured by H-index, on postural control-related variables (SDAP and Vavg) were foot sole sensitivity 
dependent. CONCLUSION: Peripheral neuropathy negatively affects postural control and functional gait. 
The severity of the disease mediates the specific effects on postural control and functional gait. 
Understanding the differential effects of the symptoms may help to design specifically tailored 
rehabilitation protocols.  
INDEX WORDS: Peripheral neuropathy, H-index, Foot sole sensitivity, Postural control, Functional gait, 
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Peripheral Neuropathy (PN) is a degenerative disease that mainly affects the peripheral sensory 
nerve (Li, Zhang, & Dobson, 2019; Martyn & Hughes, 1997). PN may be caused by diabetes mellitus, 
human immunodeficiency virus, or chemotherapy (Watson & Dyck, 2015). Millions of people are 
affected by this disease and may have positive (e.g., burning, tingling, allodynia, and hyperalgesia) or 
negative symptoms (e.g., loss of tactile sensation, proprioception, and temperature sensitivity)(Centers for 
Disease Control and Prevention, 2020). Common complications of PN are neuropathic pain and diabetic 
foot (Garcia-Morales et al., 2011; Smith & Torrance, 2012). The symptoms and/or complications 
negatively affect quality of life (Li & Hondzinski, 2012), the ability to complete activities of daily living, 
and sense of independence (Resnick et al., 2002). Older individuals with PN are at a higher risk of falling 
(Wallace et al., 2002). The leading reason for hospital or nursing home admissions in this population are 
fall related injuries, such as fractures or traumatic brain injuries (Pfortmueller et al., 2014). Repeated fall 
events can lead to an accumulation of medical costs (Pfortmueller et al., 2014). This population is at a 
higher risk of falling for many reasons, one of which is due to the inability to detect and delayed response 
to perturbations (Pfortmueller et al., 2014). 
Postural control is the ability to maintain ones center of pressure within their base of support by 
detecting perturbations and correcting movements that potentially lead to falls (Li et al., 2019). This 
ability is important for maintaining postural control during quiet stance, functional gait, and in response to 
perturbations (Anson et al., 2017). Types of tactile receptors include Merkel’s cells, Pacinian corpuscles, 
Meissner’s corpuscles, and Ruffini endings and their presence on the sole of the foot contributes greatly 
to maintaining postural control during quiet standing (Kars, Hijmans, Geertzen, & Zijlstra, 2009). 
Previous research has shown that individuals with PN had a decreased postural control capacity, defined 
by average sway velocity and area, impaired functional gait evident by a shortened 6-minute walk 
distance (6MWD), and a longer timed-up-and-go duration (TUG) (Zhang, Manor, & Li, 2015). 
Researchers have investigated the differences in postural control among older individuals with and 
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without PN and reported that there is an increase in postural sway in people with PN (Kars et al., 2009; 
Lafond, Corriveau, & Prince, 2004; Toosizadeh, Mohler, Armstrong, Talal, & Najafi, 2015). It has also 
been shown that there is an inverse relationship between sway magnitude and H-index (Chen & Zhou, 
2011; Nardone, Grasso, & Schieppati, 2006). H-index is a normalized measure of an individual’s nerve 
conduction velocity. Individuals with PN have been observed to walk slower, and with greater 
magnitudes of variability (Manor, Wolenski, & Li, 2008; Zhang et al., 2015). 
The pathological components of PN, reduced foot sole sensitivity and nerve conduction velocity, 
may affect postural control and functional gait differently depending on the stage of the disease (Fulk, 
Robinson, Mondal, Storey, & Hollister, 2010). The neural pathway for active control of stance and 
walking includes five different components: information from the sensory receptors; ascending signal to 
the central nervous system; information processing in the central nervous system; descending signal to 
muscles; and finally, the translation of the signal to the alpha motor neuron. PN affects feedback control 
mainly through the reduction in foot sole sensitivity and insensitivity to postural perturbations (Li et al., 
2019; Zhang & Li, 2013). PN affects the efferent pathway by demyelination, leading to slower nerve 
conduction velocity. This in turn influences the speed at which an individual reacts to detected 
perturbations (Bonnet & Lepeut, 2011) and the completion of functional gait tests (Lange-Maia et al., 
2016). These pathological components of PN have been investigated, either isolated or combined, and it 
has been determined that individuals with PN have decreased postural control and impaired functional 
gait. However, no research was found that addresses the differential effects of each component on 
postural control and functional gait in adults over the age of 65 years.  
Therefore, the purpose of this study was to assess the differential effects of reduced foot sole 
sensitivity and nerve conduction velocity on postural control and functional gait. It was hypothesized that  
reduced foot sole sensitivity and slowed nerve conduction velocity will affect postural control and 
functional gait differentially. It was further hypothesized that the relationship between the dependent 
variables and reduced foot sole sensitivity or slowed nerve conduction velocity will be significantly 





Prior to participant recruitment, this study was approved by the Institutional Review Board at 
Georgia Southern University. Thirty-eight participants were recruited from the local community and 
briefed about the testing procedures. Individuals were able to participate in the study if they met the 
following inclusion criteria: 1) over the age of 65 years old; 2) able to stand for a minimum of 5 min; 3) 
able to walk unassisted for at least 6 min; 4) did not have a history or evidence of central nervous system 
dysfunction; 5) did not have foot sole ulcers; 6). did not have a cardiac pacemaker implant; and 7). did not 
answer “yes” to any of the follow-up questions on the Physical Activity Readiness Questionnaire plus 
(PAR-Q+) and did not participate in any type of exercise. 
At the beginning of the testing session, required forms and assessments were completed, 
including informed consent, medical history, and a PAR-Q+. Anthropometric data (i.e., age, sex, height, 
body mass) were also collected. Then foot sole sensitivity, Hoffmann reflex, postural control, and 
functional gait were tested. 
Foot sole sensitivity was assessed using a 5.07-gauge Semmes-Weinstein monofilament (North 
Coast Medical, Inc, Morgan Hill, CA, USA) according to established protocol (Manor, Doherty, & Li, 
2008). Testing sites included the hallux, bases of first and fifth metatarsals, midsole, and heel. This 
method has been used in this population and has been deemed reliable (Manor, Doherty, et al., 2008). 
Hoffmann reflex test was conducted in a standing position. A surface electromyography (EMG) 
electrode (Trigno Wireless EMG System; Delsys Inc., Massachusetts, USA) was placed on the lateral 
gastrocnemius on the declared dominant leg of the participant, according to established protocal 
(SENIAM, 2020). The confirmative answer to the question, “what foot would you kick a ball with?” 
established leg dominance. Prior to placement, the skin was cleaned with an alcohol prep pad and shaved 
with a disposable razor, if necessary. After EMG surface electrodes were placed, a 5 cm × 8 cm anode 
and 2 cm diameter cathode were placed over the patella and popliteal fossa, respectively (Figure 1). Nerve 
conduction velocity was represented by the H-index, which considers body height in the conduction 
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velocity test results . The latency between the onsets of the M- (TM ) and H-wave (TH ) (ms) and the height 
(cm) of the individual was used to calculate the lateral gastrocnemius H-index (Equation 1). 
H-index = (𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻ℎ𝑡𝑡 (𝑐𝑐𝑐𝑐)
𝑇𝑇𝑀𝑀−𝑇𝑇𝐻𝐻
)2 × 2     (1) 
 
Figure 1. Electromyography placement on the lateral gastrocnemius. Electrical stimulation electrodes 
placed over the patella (Anode) and the popliteal fossa (Cathode). 
 
During the process of setting up the recruitment curve, the participant stood with feet about 
shoulder-width apart, arms relaxed by their side, wore noise-canceling headphones, and was instructed to 
stare at a visual point that was set at eye level. A 500 µs square-pulse single stimulus was delivered to the 
tibial nerve by an electrical nerve stimulator (Digitimer model DS7A, Digitimer Ltd., Welwyn Garden 
City, England). Stimulation intensity began at 5 mA and increased in small increments of 2 mA until 65 
mA was reached. Stimulation intervals were separated by 10 s. There was a 10 min rest following the 
Hoffman’s reflex test before the postural control assessment. Reliability of H-index for this position has 
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been deemed “good” (unpublished data). The recruitment curve was imperative to determine the 
maximum M- and H- waves. Maximum amplitude was measured from peak to peak. The M-waves 
typical behavior is a gradual increase in amplitude, whereas the pattern of the H-wave is a gradual 
increase in amplitude, then it reaches a plateau (Chen & Zhou, 2011). The intensity at which maximum 
H-wave occurred was used to determine the latency period.  
Postural control was assessed using an Accusway force plate (AMTI, Watertown, MA, 
USA) at a sampling rate of 1,000 Hz. Data were collected using the AMTI Netforce Software. 
Participants stood with their heels 10 cm apart with feet 10o abducted for 30 s with their eyes opened 
(Manor, Doherty, et al., 2008). Postural control variables were the standard deviation of center of pressure 
movement in the anterior-posterior direction (SDAP) and the average velocity of the center of pressure 
movement (Vavg). 
Functional gait was assessed using the 6MWD and the TUG tests. The 6MWD test, cones were 
placed 30 m apart, as well as taped markers every meter along a brightly lighted hallway. Participants 
were instructed to walk at a self-selected pace between the cones for six min. The distance covered in six 
min was recorded to the nearest meter (Manor, Doherty, et al., 2008). The TUG test consisted of having 
the participant begin seated with their back against an armchair. The participant was instructed to stand up 
from the chair, walk around a cone that was set 3 m away and back to the seated position. Three meters 
was determined from the front edge of the chair, and the timer started when the participant initiated 
movement and stopped when the participant sat against the back of the armchair (Manor, Doherty, et al., 
2008). A total of 3 trials were conducted, and the average duration was used in the analysis.  
Statistical analysis was performed using SPSS 25 (IBM, Armonk, NY). The differential effects of 
reduced foot sole sensitivity and H-index on postural control (SDAP & Vavg) and functional gait (TUG & 
6MWD) were assessed using a one-way multivariate analysis of variance (MANOVA), discriminant 
analysis, and multiple univariate analysis of variance (ANOVA).  
To understand the magnitude that each dependent variable contributed to the separation between 
groups the MANOVA was followed up with a discriminant analysis. There were 35 observations included 
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in the discriminant analysis. Entry level value for the analysis was set to 0.05, and the removal value was 
set to 0.01. Alpha level for all statistical tests was set at 0.05. 
After a significant MANOVA, multiple ANOVAs with Least Significant Difference (LSD) post-
hoc tests were conducted to observe what dependent variable was significantly different between the 
groups. Effect sizes were determined using Cohen’s d (𝐶𝐶𝐶𝐶ℎ𝑒𝑒𝑛𝑛′𝑠𝑠 𝑑𝑑 =  |𝑀𝑀2−𝑀𝑀1|
𝑆𝑆𝑆𝑆𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝
 ), where M1 and M2 are the 
group means, and SDpooled is the pooled standard deviations of both groups. The criteria for  evaluating 
effect size were d <0.2, 0.2≤ d <0.5, 0.5≤ d <0.8, and d≥0.8 for very small, small, medium, and large, 
respectively. 
To assess the relationship between the main clinical symptoms and the postural control and 
functional gait variables, Pearson product correlations were run within each group. The correlation 
coefficients of each group within the variables being assessed were compared using 95% confidence 
intervals (CI) (Li & Caldwell, 1999). The correlation was deemed significantly different from zero if the 






Thirty-eight participants (19 females; 19 males) were recruited for this study. Three individuals (1 
female; 2 males) were excluded from the data analysis due to the inability to identify the onset of the M- 
and H-waves in their lateral gastrocnemius muscles.  
Table 1. Means and Standard Errors of the Mean for Individual Group Characteristics 
Group LA (range) MA (range) SA (range) 
Age (Years old) 73±2 (65-81) 74±2 (67-84) 73±1 (66-81) 
F/M (N) 7F/3M 7F/5M 4F/9M 
Body Mass (kg)  68.4±3.5 (45-81) 77.2±4.1 (51-100) 95.2±6.5 (65-140) 
Height (m) 1.62±0.02 (1.53-1.71) 1.65±0.02 (1.55-1.78) 1.73±0.03 (1.55-1.88) 
BMI (kg/m2) 26.1±1.4 (18.2-32.1) 28.2±1.2 (21.3-33.3) 31.3±1.4 (22.6-40) 
H-Index (cm2/ms2) 89.7±3.4 (78.0-109.4) 60.2±3.4 (42.8-76.6) 61.8±2.1 (45.6-75.5) 
Foot Sole Sensitivity 8.6±0.5 (6-10) 8.7±0.5 (6-10) 2.2±0.6 (0-5) 
Note. LA: Less Affected group, MA: Moderately affected group, SA: Severely affected group  
Participants were grouped based on the severity of reduced foot sole sensitivity and slowed 
conduction velocity to study the differential effects of the two most significant movement related 
symptoms on postural control and functional gait. Participants were first grouped based on their foot sole 
sensitivity scores, 0-5 and 6-10. The group with more severe sensation loss (0-5) had a maximum H-index 
at just below 78 cm2/ms2. The groups were then further subdivided for those with less foot sole sensitivity 
loss (6-10) into two groups based on their H-index scores: less and greater than 78 cm2/ms2. This created 
three groups. Group 1 was less affected (LA) by the pathology (foot sole sensitivity 6-10, H-index ≥ 
78cm2/ms2); Group 2 was moderately affected (MA) by the pathology (foot sole sensitivity 6-10, H-index 
< 78cm2/ms2); and Group 3 was severely affected (SA) by the pathology (foot sole sensitivity 0-5, H-
index < 78 cm2/ms2). Anthropometrics and average H-index and foot sole sensitivity scores for each 
group are presented in Table 1.  
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According to the One-way MANOVA analysis there was a significant difference between the 
groups (F4,30=3.752, p=0.014, partial η2=0.333). The discriminant analysis revealed that the centroid 
locations of each group had the most separation for the linear discriminant function 1. In contrast, there 
was not a significant separation with linear discriminant function 2 (Figure 2). The primary determinant 
for this separation was Vavg, along with the 6MWD and TUG contributing as the secondary determinants 
for linear discriminant function 1 (See Table 2 for more details).  
 
 
Figure 2. Graphical representation of the separation between the groups based on their centroid location. 
The discriminant analysis revealed that the greatest separation between the least affected (LA) & severely 
affected (SA) were for the linear discriminant function 1, whereas minute separation was observed for 







Table 2. Results of Discriminant Function Analysis 
  Structure Matrix 
Variables 
Correlation Coefficients 






Note. Vavg: Average velocity of the center of pressure movement, 6MWD: 6-minute walk distance, TUG: 
Timed-up-and-go, SDAP: Standard deviation of the center of pressure movement in the anterior-posterior 
direction, Wilk's Lambda = 0.635, p=0.086; *denote significant contributors. 
 
Multiple univariate one-way ANOVAs with a LSD adjustment was performed after a significant 
MANOVA. There was a significant difference observed for Vavg (F2=5.344, p=0.010, partial η2 =0.250). 
There were no statistically significant differences observed for SDAP (F2=0.370, p=0.694 partial 
η2=0.023), 6MWD (F2=2.098, p=0.139, partial η2=0.116), and TUG (F2=1.749, p=0.190, partial 
η2=0.099).  
Pairwise comparisons using LSD post-hoc analysis were conducted for the postural control and 
functional gait parameters (See Figure 3A-D for more details). Significant differences were observed 
between groups LA and SA for Vavg (p=0.003, d=1.291). Effect sizes were calculated for each of the 
pairwise comparisons and results are displayed on the right panel of Figure 3. Very small effect sizes 
were observed between LA and MA (d=0.172) for 6MWD, SDAP (d=0.019). Small effect sizes were 
observed between LA and MA (d=0.415), and MA and SA (d=0.290) for TUG, LA and SA (d=0.280) and 
MA and SA (d=0.329) for SDAP. Medium effect sizes were observed for LA and SA (d=0.792), MA and 
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SA (d=0.601) for 6MWD, as well as LA and MA for Vavg. Large effect sizes were observed for LA and 
SA (d=0.888) for TUG, LA and SA (d=1.291), and MA and SA (d=0.803) for Vavg. 
 
Figure 3A-D. Means and Standard Errors of the Means of the functional gait (A, B) and postural control 
(C, D) variables. LA, MA, and SA denote for the less, moderately, and severely affected groups, 
respectively. A. 6MWD: 6-minute walk distance, B. TUG: Timed-up-and-go, C. SDAP: Standard 
deviation of the center of pressure movement in the anterior-posterior direction, and D. Vavg: Average 
velocity of the center of pressure movement. Pairwise comparison Cohen’s d are listed to the right of the 
figures. It is categorized based on the following: very small (d <0.2), small (0.20 ≤ d <0.50), medium 
(0.50 ≤ d <0.80) and large (d ≤0.80) *indicates significant differences (p<0.05). 
 
The relationship between foot sole sensitivity, H-index, and the dependent variables for all three 
groups are presented in Figures 4 and 5. The correlation was deemed significant if the 95% CI did not 
cross zero. See Table 3 for detailed results. The list of significant correlations with foot sole sensitivity 
observed includes, Group LA & SA: 6MWD; Group LA & MA: TUG; Group LA: SDAP; and Group MA: 
Vavg. Significant correlations with H-index were observed from: Group LA & MA: 6MWD; Group LA & 





Figure 4A-D. Pearson product correlation for Foot Sole Sensitivity and Dependent Variables. Functional 
gait variables are presented in A& B, postural variables in C & D. A. 6MWD: 6-minute walk distance, B. 
TUG: Timed-up-and-go, C. SDAP: Standard deviation of the center of pressure movement in the anterior-
posterior direction, and D. Vavg: Average velocity of the center of pressure movement. Groups were LA 





Figure 5A-D. Pearson product correlations between H-index and Dependent Variables. Functional gait 
variables are presented in A & B, postural variables in C & D. A. 6MWD: 6-minute walk distance, B. 
TUG: Timed-up-and-go, C. SDAP: Standard deviation of the center of pressure movement in the anterior-
posterior direction, and D. Vavg: Average velocity of the center of pressure movement. Groups were LA 





Table 3. Linear Relationship between Functional Gait and Postural Variables and Foot Sole Sensitivity 
and H-index 
      Foot Sole Sensitivity   H-index  
  Group 
 
R 95% CI 
 




0.860*  0.737,0.927 
 
0.523*  0.229,0.729 
MA 
 
0.044  -0.294,0.372 
 
-0.535*  -0.737,-0.245 
SA 
 
-0.569*  -0.758,-0.290 
 




-0.588*  -0.770,-0.316 
 
-0.716*  -0.502,-0.847 
MA 
 
0.364*  0.036,0.622 
 
0.381*  0.055,0.634 
SA 
 
0.274  -0.065,0.556 
 




0.498*  0.198,0.713 
 
0.116  -0.226,0.433 
MA 
 
-0.131  -0.444,0.212 
 
-0.100  -0.419,0.242 
SA 
 
0.199  -0.143,0.499 
 




-0.326  -0.595,0.007 
 
0.000  -0.333,0.333 
MA 
 
0.466*  0.158,0.692 
 
-0.622*  -0.791,-0.364, 
SA 
 
0.069  -0.271,0.393 
 
0.412*  0.091,0.655 
Note. LA: Less affected group, MA: Moderately affected group, SA: Severely affected, 6MWD: 6-minute 
walk distance, TUG: Timed-up-and-go, SDAP: Standard deviation of the center of pressure movement in 
the anterior-posterior direction, Vavg: Average velocity of the center of pressure movement R: Correlation 
coefficient, 95% CI: 95% Confidence Interval. * indicates that the correlation coefficient is significantly 






The purpose of this study was to assess the differential effects of reduced foot sole sensitivity and 
nerve conduction velocity on postural control and functional gait. The first hypothesis was partially 
supported because the clinical symptoms affected postural control and functional gait differentially. SA 
individuals differed primarily in Vavg compared to LA individuals. However, functional gait variables 
were secondary contributors to the separation between the groups. The second hypothesis was partially 
supported as the clinical and outcome measures depended on the severity of the disease. An increase in 
pathology negatively affected functional gait for LA and these relationships were only consistently 
significant within LA. Inconsistent trends were observed as only one of the clinical measures significantly 
affected one of the outcome measures. For example, H-index affected 6MWD of LA negatively, but the 
same relationship had the opposite trend in MA. For another example, reduced H-index, but not foot sole 
sensitivity, negatively affected Vavg. Finally, Vavg reacted to the clinical declines differently within MA. 
Decreased Vavg was associated with decreased foot sole sensitivity, but increased Vavg was significantly 
related to decreased H-index.  
 The results of the determinant analysis showed that Vavg is the primary determinent that separates 
LA from SA, whereas the functional gait parameters only served as secondary determinants. This meant 
that disease progression affected postural control more than functional gait and supports the Zhang and Li 
results (Zhang & Li, 2013). They suggested that postural control heavily relies on feedback control where 
functional gait is mainly controlled through feedforward mechanisms (Zhang & Li, 2013). PN mainly 
affects foot sole sensitivity and sensory nerves, which affects the feedback control more than the 
feedforward control. Furthermore, a significant negative relationship between Vavg and H-index among 
MA found here is similar to what Zhang and colleagues (2015) reported. However, this relationship was 
not observed for SA, which was similar to the mean of the PN group in their study. A potential reason for 
this difference may be that the H-index was recorded in the prone position in their study, but in standing 
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in ours. Position changes have been shown to influence Hoffmann reflex (Alrowayeh, Sabbahi, & Etnyre, 
2011; Tokuno, Garland, Carpenter, Thorstensson, & Cresswell, 2008). 
 We have separated the two main symptoms of PN: foot sole sensitivity and nerve conduction 
velocity, to study their differential effects on postural control and functional gait. No studies were found 
that studied differential effects in this way. For instance, nerve conduction velocity of MA was much 
lower compared to LA, whereas foot sole sensitivity was reduced comparing MA to SA. When the 
variables are compared between groups and evaluated, a significant difference in Vavg was observed 
between LA and SA. In conjunction with the discriminant analysis, this difference implies that as the 
severity of the disease increases, postural control is the main factor that separates LA from SA.  
Furthermore, the differential influences of the two symptoms became apparent with our way of 
grouping the participants. For example, foot sole sensitivity for LA and MA were in similar range (6-10), 
but its correlation with Vavg behaved oppositely. Reduction of foot sole sensitivity was significantly 
associated with decreasing Vavg in MA, but with increasing Vavg in LA, although the latter association was 
not significant. This difference might be related to MA having a much lower nerve conduction velocity 
than LA. Without the conduction velocity reduction (LA), Vavg would increase with the reduction of foot 
sole sensitivity (Wang & Lin, 2008). However, with the reduced conduction velocity (MA), movement 
control strategy and adaptation to the loss of foot sole sensitivity could be very different. This 
phenomenon, that H-index mediated the relationship between functional outcomes and foot sole sensation 
can be seen on the right side of all four Figure 4 panels (A-D). Mediatation was apparent as LA and MA 
correleations were opposite. The H-index mediated relationship between foot sole sensitivity and 
functional movements (both postural control and functional gait) has not been found in the literature. 
 Nerve conduction velocity between MA and SA had a similar range (H-index was roughly in the 
40 – 78 cm2/ms2 range), and its correlation with Vavg was different between groups. A decreased H-index 
was significantly correlated with the increase of Vavg in MA. This negative correlation has been reported 
in the literature (Zhang et al., 2015). However, within SA, nerve conduction velocity decrease was 
significantly correlated with Vavg increase. These two significant relationships indicate a foot sole 
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sensitivity mediated relationship between nerve conduction velocity and postural control since foot sole 
sensitivity was different between MA (6-10) and SA (0-5). However, we did not observe foot sole 
sensitivity mediated relationships between H-index and functional gait in MA and SA, where both were in 
the same direction albeit not all were significant.  
Based on the observations from Figures 4 and 5, nerve conduction velocity meditates the 
relationship between foot sole sensitivity and both postural control and functional gait, where foot sole 
sensation only mediates the relationship between H-index and postural control, but not that of functional 
gait.  
PN is a progressive disease and its adverse effects on postural control and functional gait 
increases. If we are able to understand the reasons for PN-related movement disorders (e.g., loss foot sole 
sensitivity or slowed nerve conduction velocity) then training programs can be adjusted or tailored 
accordingly. Our results showed that the improvement in foot sole sensation can positively affect postural 
control and functional gait when there is not a reduction in nerve conduction velocity, however, when 
there is already a reduction in H-index an improvement in foot sole sensitivity does not have the same 
effect. The results from this study show that early intervention may be critical to reduce or reverse the 
effects of PN on postural control and functional gait. Specific types of exercises have been shown to 
influence the clinical symptoms of neuropathy positively. For instance, Tai Chi has been shown as a 
successful early intervention for individuals who have a moderate reduction in foot sole sensitivity. It has 
been reported that foot sole sensitivity and functional gait, both 6MWD and TUG improved after 24 
weeks of modified Tai Chi training (Li & Manor, 2010). However, their study did not measure H-index. 
Otherwise, it could be suggested that there was an increase in H-index as well, based on the positive 
correlation observed in LA between H-index and 6MWD. Other studies have investigated the benefits of 
resistance and aerobic exercises (Dixit, Maiya, & Shastry, 2014; Kruse, Lemaster, & Madsen, 2010; 
Singleton, Smith, & Marcus, 2015) as well as postural control training (Powell-Cope, Quigley, 
Besterman-Dahan, & Lind, 2014) for this population. Exercise can positively affect postural control 
capacity and functional gait. Older adults are encouraged to participate in exercise because it can help 
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decrease the chances of a fall and interrupt the progression of the disease (Pfortmueller et al., 2014). Our 
results support the notion that exercise can help reverse the vicious cycle of PN brought to people and 
improve their quality of life (Li & Hondzinski, 2012).  
 There are a few limitations to this study. For example, individuals recruited were either healthy or 
diagnosed with diabetes, diabetic neuropathy, or idiopathic neuropathy. The presence of diabetes 
potentially affects the vestibular system biologically (D'Silva, Lin, Staecker, Whitney, & Kluding, 2016). 
We do not know the contribution of vestibular system deterioration to our postural control tests. Timing 
of the day sensitivity and the number of steps taken have been shown to impact foot sole sensitivity 
(Alfuth & Rosenbaum, 2011), but was not controlled in our protocol. Factors that could affect the results 
of Hoffman’s reflex, but were not controlled are the following: postural anxiety, fatigue, possible 
oligosynaptic spinal cord pathways (Chen & Zhou, 2011). We also did not record current medication 
intake and understand that participants may have been taking medications that are related to falling 
(Stolze et al., 2004). Those factors need to be better controlled in future studies. However, these factors 
were not likely to have a systematic effect on our observations due to the randomized nature of our data 
collection process. 
 Ankle joint proprioception and leg strength have been reported to affect functional gait among 
people with PN (Li et al., 2019; Manor, Doherty, et al., 2008). Future research should compare the 
influences of ankle joint proprioception and leg strength with impacts of the clinical outcome measures on 
functional gait among this population. This comparison can help us to understand the influence of PN 
progression on strength and ankle joint proprioception. Furthermore, a more thorough investigation of PN 
severity and extensive postural control ability (i.e., tandem walking or berg balance tests) is suggested to 
understand the severity of PN and dynamic postural control. The addition of more challenging tasks 
combined with the effects of the deterioration of Hoffman’s reflex outcomes will give us more 
information on the influence of PN on movement control (Richardson, Thies, DeMott, & Ashton-Miller, 
2004a, 2004b). H- and M-wave ratio has been shown to behave differently in different populations and 
positions (Alrowayeh et al., 2011; Angulo-Kinzler, Mynark, & Koceja, 1998; Capaday & Stein, 1986). 
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Studying the H/M ratio can give insight to neural adaptations that may be occurring as a result of PN 
(Angulo-Kinzler et al., 1998; Li et al., 2019).  
CONCLUSION 
Postural control and functional gait are impaired in individuals with PN because of the loss of 
foot sole sensitivity and slowed nerve conduction velocity. This study aimed to better understand the 
differential effects of the two main clinical symptoms of the disease on postural control and functional 
gait in older adults. We have observed that PN negatively impacts postural control and functional gait. 
The differential effects of reduced foot sole sensitivity and slowed nerve conduction velocity on postural 
control and functional gait were severity dependent. A deeper understanding of the impact of the clinical 
measures on postural control and functional gait can help us tailor rehabilitation and training programs 
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APPENDIX A: PROPOSAL DOCUMENT 
Diabetic Neuropathy and Quality of Life 
Diabetes Mellitus and Quality of Life 
Over 23.1 million people are currently diagnosed with diabetes mellitus, with 25.2% being older 
adults over 65 years old (CDC, 2019). Diabetes Mellitus is an overarching group of diseases that are 
characterized by a defect in insulin secretion or insulin action that leads to hyperglycemia. Insulin action 
can be a result of inadequate insulin secretion and/or diminished tissue responses to insulin at many 
different points of the hormone pathway (American Diabetes Association, 2013; Kerner & Brückel, 
2014). The pancreatic beta cells in people with diabetes are destroyed, which leads to insulin deficiency 
(American Diabetes Association, 2013; Kerner & Brückel, 2014). Hypoglycemia symptoms include 
polyuria (an abnormal production large amount of diluted urine), polydipsia (abnormally thirsty), weight 
loss, occasionally polyphagia (excessive hunger), and blurred vision (American Diabetes Association, 
2013; Kerner & Brückel, 2014). There are two main types of diabetes. Type 1 diabetes is defined as an 
absolute deficiency of insulin secretion and affects 5-10% of the population, whereas Type II diabetes 
affects 90-95% of the population (American Diabetes Association, 2013; Zheng, Ley, & Hu, 2018). Type 
II Diabetes is defined as insulin resistance and inadequate compensatory insulin secretory response 
(American Diabetes Association, 2013). Risk factors for type II diabetes, the most common type of 
diabetes, are excess adipose tissue around the abdomen, obesity indicated by a high body mass index, age, 
physical inactivity, or ambient air pollution, or some medications (American Diabetes Association, 2013; 
Zheng, Ley, & Hu, 2018). When diagnosing individuals with diabetes mellitus, plasma glucose or HbA1c 
levels are tested. The following is the set criteria: HbAlc ≥ 6.5%( ≥ 48mmol/mol), random plasma 
glucose ≥ 200mg/dl ( ≥ 11.1 mmol/l), fasting plasma glucose ≥ 126mg/dl ( ≥7.0mmol/dl), or OGTT 2-
hour glucose in venous plasma ≥ 200mg/dl ( ≥ 11.1 mmol/l) (Kerner & Brückel, 2014). Long term effects 
of type II diabetes include increased risk of musculoskeletal, cardiovascular, hepatic, or digestive 
disorders as well as an increase in liver, pancreas, endometrium cancers and comorbidities such as non-
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alcoholic fatty liver disease, obstructive sleep apnea, depression, infection, or neuropathy (Zheng et al., 
2018). 
 Individuals with diabetes have an average of 8 years of reduction in their lifespan and exhibit a 
decreased quality of life (QoL) (Zheng et al., 2018). Diabetic foot ulcers and other diabetic complications 
are related to the reduced quality of life and increased medical expenses. Previous research has shown 
that age, presence of type II diabetes, increase the severity of the ulcers, lesion progression, the number of 
ulcers contributes to a decrease in the physical and psychological function (Garcia-Morales, Lazaro-
Martinez, Martinez-Hernandez, Aragόn-Sánchez, Beneit-Montesinos, & González-Jurado, 2011). The 
diabetic foot has been shown to have a greater impact on QoL when compared to the impact of 
neuropathy and pain symptoms. This condition may affect QoL because the treatment for diabetic foot 
includes staying off the affected foot which impairs mobility and ability to perform activities of daily 
living, and severe impairment may lead to quitting jobs and increasing psychological and social impact 
(Garcia-Morales et al., 2011).  
Peripheral Neuropathy and Quality of Life 
Peripheral neuropathy is a heterogeneous and symmetric condition with the defining 
characteristic of damaged axons and/or myelin of  ≥ 1 peripheral nerve (Li, Zhang, & Dobson, 2018). PN 
may be caused by diabetes mellitus, human immunodeficiency virus, chemotherapy, or dysproteinemia 
disorders (Watson & Dyck, 2015). Individuals with PN may be asymptomatic; however, some may 
experience positive symptoms such as sensations of burning, tingling, prickling, and amplified response 
to pain, as well as negative symptoms like loss of tactile sensation, proprioception, loss of muscle 
strength, and temperature sensitivity (Li, & Manor, 2010; Timar et al., 2016; Azhary, Muhammad, Minal, 
Arshad, & Mounzer, 2015). This degradation of sensory feedback progress in a distal to the proximal 
manner (Li et al., 2018; Richardson, Ching, & Hurvitz, 1992; Davies, Brophy, Williams, & Taylor, 2006; 
Ghanavati, Yazdi, Goharpey, & Arastoo, 2012). Individuals with peripheral neuropathy also exhibit 
bilateral deficits in the absence of ankle reflexes, insensitivity to touch, vibration, and position (Mold, 
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Vesely, Keyl, Schenk, & Roberts, 2004) and loss of sensation in their feet (Dros, Wewerinke, Bindels, & 
Weert, 2009). 
Two-thirds of individuals with PN may experience neuropathic pain (Girach et al., 2019), which 
is defined as “pain arising as a direct consequence of a lesion or disease affecting the somatosensory 
system” (Smith & Torrance, 2012). For example, neuropathic pain can be a resultant of allodynia, or 
associated comorbidities such as depression, anxiety, and sleep disturbances (Watson & Dyck, 2015; 
Davies et al., 2006 ). This pain increases health care facilities usage which increases medical expenses, 
increases personal financial burden because of the inability to work (Smith & Torrance, 2012; Girach et 
al., 2019). Risk factors for neuropathic pain are older age, female sex, manual occupation, inability to 
work, rural environment, and lower education level (Smith & Torrance, 2012). Also, individuals with PN 
may not be able to perform ADLs or tasks they previously did (Ghanavati et al., 2012). 
A series of tests may be performed to diagnose PN and DPN. These include vibration perception, 
application of warmth and cold, and nerve conduction velocity studies. Monofilament testing, using 
Semmes-Weinstein calibrated monofilaments, is typically used as an inexpensive way to quantify reduced 
foot sole tactile sensation (Dros et al., 2009). The most common monofilament used to diagnose reduced 
foot sole sensation is 4.17, 5.07, and 6.10 (Dros et al., 2009). For this test, the monofilament wire contacts 
different parts of each foot three times. These areas are hallux, first and fifth metatarsal, midsole, and 
heel. Scoring for this test follows a standard protocol (Li & Manor, 2010). Nerve conduction velocity 
(NCV) testing is the lead assessment for diagnosing PN. Using the height of the individual divided by the 
onset of the maximum M-wave (MMax) and H-wave (HMax), the NCV can be calculated. NCV is reduced 
in individuals with PN and DPN. When an individual has diabetes, there may be an added effect of 
delayed muscle activation (Bonnet & Lepeut, 2011; Li et al., 2018). The amplitude of the M and H waves 
may suggest that demyelination or axonal degeneration has occurred (Boulton et al., 2005). For example, 
a lower amplitude may indicate axonal damage, whereas prolonged latency and slow conduction velocity 
may suggest demyelination (Azhary et al., 2015). The reduction in amplitude has been linked to impaired 
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glycemic control, abnormal sensation, decreased QoL (Li et al., 2018). The severity of peripheral 
neuropathy can be quantified using NCV and monofilament testing scores. 
A research study in the United Kingdom determined that individuals with neuropathic pain, their 
health-related QoL is severely affected in comparison to those without neuropathic pain. QoL was 
assessed using the Short form 36 general health questionnaire. Another systematic review evaluated the 
role neuropathic pain plays in individuals with different causes, including diabetic neuropathy. Out of the 
19 tools that were used to assess QoL, 34.8% used the SF-36 form to determine that QoL was severely 
impacted by neuropathic pain (Girach et al., 2019). 
Diabetic Neuropathy and Quality of life 
Out of the individuals diagnosed with diabetes, it is estimated that about one-half have peripheral 
neuropathy as a result (CDC, 2019). Diabetic Neuropathy (DPN) is a common progressive type of 
peripheral neuropathy that is the result of long-term diabetes (Kim et al., 2014; Eftekhar-Sadat, Azizi, 
Aliagharzadeh, Toopchizadeh, & Ghojazadeh, 2015). DPN is diagnosed when all other causes have been 
ruled out (Boulton et al., 2005). DPN can also be described as a long-term diabetic complication (Van 
Acker et al., 2009). Risk factors for DPN include: older age, sustained duration of diabetes, poor glycemic 
control, gender, height, insulin therapy, smoking status, obesity, alcohol consumption, high body mass 
index, elevated systolic blood pressure, high triglyceride levels, low HDL cholesterol, or presences of 
peripheral vascular disease, retinopathy or nephropathy (Van Acker et al., 2009; Davies et al., 2006). Out 
of the individuals diagnosed with DPN, 10-20% require some treatments for their symptoms (Van Acker 
et al., 2009). Individuals who have type II diabetes may experience painful DPN more often than people 
with type 1 diabetes (Van Acker et al., 2009). If left untreated, complications such as diabetic foot, 
infections, foot ulcers, bone deformities, stiffened tendons, ligaments, and plantar soft tissue, reduced 
flexibility may occur (Bonnet & Lepeut, 2011; Van Acker et al., 2009).  
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In addition to the previous PN tests mentioned, diagnosis of diabetic neuropathy may be made if 
the pain affects both lower limbs, is worse at night, not related to exertion, and not caused by other 
conditions (Davies et al., 2006). 
Symptoms can last for many years thus continuously negatively impacting QoL. Individuals with 
DPN experience a significantly higher financial burden because of the increased usage of medical 
facilities, medications, procedures, or interventions. An individual may be negatively impacted personally 
or socially (Smith & Torrance, 2012). The amount of negative impact on QoL is different between 
individuals depending on the presence of painful diabetic neuropathy. Davies and colleagues (2006) 
conducted a survey investigating the impact painful diabetic neuropathy has on QoL. It was concluded 
that there was a correlation between severity and QoL when compared to individuals without neuropathic 
pain (Davies et al., 2006). This condition puts a burden on individuals with diabetic neuropathy because 
treatment is sparse, and expenses accumulate (Davies et al., 2006).  
Compromised postural control capacities during activities of daily living (ADLs), fear of falling, 
or increased financial burden may also affect QoL (Li et al., 2002; Najafi et al., 2010; Timar et al., 2016). 
Avoidance of activities may lead to muscle atrophy, decreased lower body muscle strength, mobility, and 
physical functioning (Li et al., 2003). A research study conducted by Li and colleagues (2002) evaluated 
the relationship between fear of falling and functional ability in elder adults (age > 70 years old) and 
determined that fall-related self-efficacy acted as the mediator for this relationship (Li et al., 2002). It has 
been shown that individuals who have higher levels of fear are more likely to have decreased functional 
ability performance and reduced quality of life (Li et al., 2003) and are more likely to avoid other social 
and physical activities thus a decline in physical and mental health (Li et al., 2003). In the elderly 
population, the leading cause of hospital and emergency room admissions were due to unintentional falls, 
in which 87% result in fractures (Wallace et al. 2002). The risk of falling increases in elders with diabetes 
and peripheral neuropathy by 15% when compared to individuals without neuropathy (Wallace et al., 
2002). Hospital stays in this population are longer, which causes summation of hospital expenses. In the 
34 
 
year 2000, the direct medical costs and productivity loss total in older adults was 31 billion dollars 
(Stevens et al., 2006), which contribute to the increased financial burden for the health care system. 
Individuals with diabetes or DPN may have evidence of a decline in somatosensory, visual, and 
vestibular function, metabolic muscle function (Hewston & Deshpande, 2016). These aspects play a role 
in the increased risk of falling in this population (Hewston & Deshpande, 2016) as well as the 
reoccurrence of falls (Lafond, Corriveau, & Prince, 2004). These characteristics of diabetic neuropathy 
can affect an individual’s quality of life by increasing fear of falling, anxiety, depression, loss of mobility, 
and independence (Benbow et al., 1998; Najafi et al., 2010). Pain-related reduction of Qol occurs in 
almost 10% of this population (Benbow et al., 1998). 
Diabetic Neuropathy and Postural Control 
Postural Control Mechanisms 
 Increased risk of falling can be associated with poor postural control and can be assessed using 
quiet standing (Lafond et al., 2004). Postural control involves the musculoskeletal and neural systems, 
and describes the ability to maintain, correct, or achieve Stable postural control during any activities (Li et 
al., 2018). Stable postural control describes the ability to maintain an individual’s center of mass within 
their base of support (Palmieri et al., 2002). During a quiet stance, the body naturally sways in an inverted 
pendulum motion (Li et al., 2018). Since the body is a multilinked system, it uses ankle or hip strategies 
to maintain the center of mass within the base of support in the anteroposterior and mediolateral 
directions, respectively (Bonnet & Lepeut, 2011). Analysis of the center of pressure 95% sway area and 
sway velocity can be used to describe the postural control behavior (Toosizadeh, Mohler, Armstrong, 
Talal, Majafi, 2015). Postural sway measures the magnitude and direction of an individual’s center of 
pressure moves (Palmieri, Ingersoll, Stone, & Krause, 2002). The center of pressure is defined as the 
vertical projection of an individual’s center of mass and can explain the force distribution occurring at the 
ground level (Chen & Zhou, 2011; Winter, 1995). The direction in which individual sways can give 
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insight to what adaptive strategy is being used. For instance, for smaller sway magnitude in the 
anteroposterior direction can be associated with the ankle strategy, whereas sway in the mediolateral 
direction is an indicator of hip strategy (Winter, 1995). During postural control, different systems help the 
individual maintain their stability, or center of pressure within their base of support (Chen & Zhou, 2011).  
The vestibular, visual, and somatosensory systems contribute sensory information to help 
maintain postural control stability (Hewston & Deshpande, 2015; Lafond et al., 2004; Bonnet & Lepeut, 
2011). The vestibular systems’ role is to provide information regarding the head’s position and the spatial 
orientation (Hewston & Deshpande, 2016). The somatosensory system provides information about where 
the body’s segments are relative to each other. This system includes proprioception and cutaneous 
sensation. Proprioception includes muscle spindles, Golgi tendon organs, and joint receptors, and they are 
responsible for detecting changes in movement and sending the information to the central nervous system 
(Chen & Zhou, 2011). For postural stability, the proprioception and cutaneous receptors at the legs and 
bottom of the feet have been shown to contribute significantly (Bonnet & Lepeut, 2011; Eftekhar-Sadat et 
al., 2015). Cutaneous receptors can detect pressure, mechanical stimuli, temperature, and pain. Each 
receptor provides feedback that allows the body to adjust to any changes in body position (Chen & Zhou, 
2011). The primary tactile receptors in the skin are Merkel’s cell, Pacinian corpuscles, Meissner’s 
corpuscles, and Ruffini endings (Li et al., 2018). Visual input plays a vital role due to being able to 
provide feedback about contextual clues and surrounding movements (Chen & Zhou, 2011).  
 The central nervous system coordinates the control of posture and movements (El Bardawil et al., 
2013). The coordinative mechanisms include the cerebral motor cortex which generates the motor 
commands, cerebellum that plays a role in postural and locomotion control, and then the basal ganglia and 
brainstem control autonomic and voluntary movements (Chen & Zhou, 2011). Type 1a and type 11a 
afferent pathways innervate different receptors. Type Ia afferent innervates primary afferents of the 
muscle spindles, whereas type II afferent innervate secondary afferents of the muscle spindles and 
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mechanoreceptors (Zhang, Manor, & Li, 2015). Electrical stimulation and electromyography have been 
used to gain insight into the nerve signaling. 
 Postural control can be used to measure stability impairments in individuals susceptible to 
deteriorated stability performance. Age, neurological, or musculoskeletal disorders have been shown to 
impact postural control abilities (Palmieri et al., 2002). Understanding how diabetes, peripheral 
neuropathy, and diabetic neuropathy affect postural control can help gain insight on postural control 
performance, thus fall risks.  
Diabetes and Postural Control 
 People with diabetes have been shown that individuals over the age of 60 years old who are 
diagnosed with diabetes are 2.5 times more likely to fall when compared to nondiabetics (Wallance et al., 
2002). Postural control performance is negatively impacted by diabetes (Fulk et al., 2010). Fulk and 
colleagues (2010) concluded that individuals with diabetes and no peripheral neuropathy had more 
trouble reacting to small postural perturbations (Fulk et al., 2010). It was suggested that the reason for this 
is due to the vestibular system is affected by the change in blood glucose and insulin levels. People with 
diabetes are 2.3 times more likely to have trouble with detecting postural disturbances because there is an 
impairment in the translation of information regarding body position and spatial awareness (Chen & 
Zhou, 2011; Hewston & Deshpande, 2016; Fulk et al., 2010). However, hypoglycemia, a symptom of 
diabetes have been shown to damage sensory nerve fibers, thus hindering the somatosensory system’s 
feedback (Hewston & Dashpande, 2016), affect the circulatory system of the retina, cause inflammation 
and reduced sensitivity in the metabolic vasculature in the inner ear, impact mechanical and metabolic 
muscle function due to impaired glucose regulation (Hewston & Deshpande, 2016; Toosizadeh et al., 
2015). Impaired metabolic muscle function hinders the ability to increase muscle strength. Thus people 
with diabetes have been shown to have trouble performing ADLs because of the decreased muscle 
strength (Toosizadeh et al., 2015). Schwartz and colleagues tested muscular strength and tandem balance 
in women over the age of 67 who had diabetes and/or peripheral neuropathy and determined that this 
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population was at a higher risk of falling due to instability and decreased muscle strength (Schwartz et al., 
2002). 
 Studies have investigated postural control in individuals with diabetes. However, some have 
neglected to include how they screened for neuropathy, or they combined DPN and diabetes into the same 
group. When DPN was included, this group exhibited greater sway area and velocity than individuals 
with diabetes without neuropathy and healthy controls. When diabetes was isolated to its group and 
compared to the healthy control, there was a significant difference between healthy control and people 
with diabetes when examining quadriceps muscle strength, greater sway and worse sensory-motor 
function test scores (Bonnet, Carello, Turvey, 2009). 
Neuropathy and Postural Control 
 Individuals with PN facing postural control challenges (Winter, 1995). Because of this, 
individuals with PN are at a higher risk of falling and reduced mobility. PN is associated with reduced 
postural control ability and walking speed (Schwartz et al., 2002). During postural control assessments, 
individuals with PN exhibit increased postural sway magnitude. Greater sway may be due to the lack of 
ability to react to position changes due to the diminished proprioceptive and cutaneous sensory receptors 
(Li et al., 2018). 
 During postural control and functional mobility, ankle joint proprioception, and tactile sensitivity 
have been shown to play a critical role (Li et al., 2018; Menz, Morris, & Lord, 2005). Ankle 
proprioception has been previously defined as a “specialized variation of the touch sensory modality, 
which includes joint movement and joint position movements” (Zhang et al., 2014). Reduced ankle joint 
proprioception leads to increased fall risk, decreased distance covered during the 6MWD and longer TUG 





Diabetic Neuropathy and Postural Control  
Wallance and colleagues evaluated the incidence of falls, as well as the reason for an increase in 
falls in older adults. They observed that individuals with diabetic neuropathy had an increased risk of 
falling due to loss of foot sole sensation. Another study by Cavanagh and colleagues, determined that 
DPN individuals were 15 times more likely to experience fall-related injuries. It has been shown that falls 
are more common in individuals with diabetic neuropathy, specifically type II diabetes, due to the 
increase in postural sway and difficulties with sensory input (Fulk, Robinson, Mondal, Storey, & 
Hollister, 2010; Hewston & Deshpande, 2016). It has also been noted that individuals with diabetes have 
an increased postural sway, decreased peripheral sensory and motor pathways, and abnormal 
neuromuscular responses to postural disturbances and walking (Fulk et al., 2010). The reduction of 
postural control could be due to loss of somatosensory input, loss of pressure perception, decrease in 
ankle joint position sense, slower reaction time, or decreased muscle strength that is a result from 
peripheral neuropathy and diabetic complications (Fulk et al., 2010; Hewston & Deshpande, 2016; 
Richardson et al., 1992). PN has also been shown to lead to muscle atrophy in the foot, which can 
compromise bone structure (Richardson et al., 1992). 
Individuals with diabetic sensory neuropathy and the inaccuracy of proprioception feedback have 
a larger sway area magnitude and sway velocity (Lafond et al., 2004). Also, the center of pressure 
measurements are highly correlated to the increased severity of peripheral neuropathy and not necessarily 
of the diabetes mellitus (Lafond et al., 2004). Yamatoto and colleagues (2001) evaluated the center of 
pressure average area and velocity in individuals with diabetic neuropathy and concluded that the average 
area and velocity was 245% and 159% percent higher, respectively (Yamatoto et al., 2001). Another 
study using wearable technology determined that individuals with diabetic neuropathy have an increase in 
the center of mass sway by 98% and 245% during eyes open and closed conditions, respectively (Najafi et 
al., 2010). It has also been observed that individuals with diabetes have an increased rate of postural 
sway. One study reported that the rate of sway was about 49% higher individuals who have diabetic 
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neuropathy (Toosizadeh et al., 2015) and the increase was explained through reduced muscle strength, 
and lack of sensory feedback. Toosizadeh and colleagues also evaluated quiet stance performance in 
individuals with diabetic neuropathy and determined that the DPN group had a significantly higher body 
sway in the eyes open (about 74%) and eyes closed (about 87%) condition (Toosizadeh et al., 2015).   
Neural Adaptations studied using Hoffman’s reflex mechanisms 
Hoffman’s reflex mechanisms 
Neurological adaptations can be investigated through understanding two types of monosynaptic 
reflexes; stretch reflex and Hoffman’s reflex (H-reflex). Anytime there is a change in the length of a 
muscle, the muscle spindle detects this and sends a signal via afferent neurons to the spinal cord. The 
neuron synapses on the efferent excitatory neuron, causing the signal to travel to the muscle. Once the 
signal reaches the muscle, it causes the muscle to contract.  
H-reflex is like the stretch reflex because it travels the same neural pathway; however, the muscle 
contraction is the result of electrical stimulation, not the change in the muscle spindles. H-reflex is a 
valuable tool in understanding the electrical synaptic transmission of the neuromuscular system and can 
be used to understand presynaptic and postsynaptic inhibition (Palmieri, Ingersollt, & Hoffman, 2004; 
Gajewski & Mazur-Różycka, 2016; Chen & Zhou, 2011). One of the most common muscles used for 
eliciting H-reflex is the soleus, which is innervated by the tibial nerve. A stimulation is introduced into 
the mixed nerve and the response of this stimulation, i.e., H-reflex, is measured using electromyography 
(Chen & Zhou, 2011). At low intensities, the signal travels toward the spinal cord via afferent sensory 
neuron then synapses on the efferent alpha motor neuron, causing the muscle to contract. The EMG 
signals recorded related to this muscle contraction is called the H-wave. The H-wave can describe the 
recruitment behavior of the afferent neurons. Typically, type 1a afferent neurons are recruited first due to 
the decreased excitability threshold and larger diameter (Palmieri et al., 2004; Gajewski et al., 2017). If 
the signal from the 1a afferent neuron is strong enough, an excitatory postsynaptic potential will occur on 
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the alpha motor neuron causing the neurotransmitter acetylcholine to release into the neuromuscular 
junction. The release of neurotransmitters causes muscle fibers to depolarize, thus causing muscle 
contraction. When the stimulation intensity is high enough, the electrical stimulation will directly elicit 
muscle contraction, and the muscle response or M-wave is recorded by EMG (Palmieri et al., 2004; 
Gajewski et al., 2017). H-wave and M-wave are different due to the distance the signal has to travel 
before its tracing is seen on the EMG. The time it takes to show up is referred to as the latency period. 
Latency periods for the H-wave and M-wave are 30 milliseconds and 4 to 5 milliseconds, respectively 
(Palmieri et al., 2004; Gajewski et al., 2017).   
A common method for determining an individual’s maximum H and M-wave is through a 
recruitment curve. This curve can be determined using the following procedure. The stimulation starts at a 
low intensity and gradually increases stimulation until a maximum M-wave (MMax) is determined. 
Usually, stimulation current is increased in 1.2 to 2.5 milliamps (mA) increments (Chen & Zhou, 2011; 
Palmieri et al., 2004; Gajewski et al., 2017). As stimulation increases the magnitude of the H and M-wave 
increases because of the increase in motor unit recruitment. H-wave will gradually increase as stimulation 
increases but will reach a peak and then begin to decrease. The reduction of H-wave peak magnitude is 
due to the antidromic collision of the electrical activity that is traveling to and from the spinal cord along 
the same pathway. Antidromic collisions can be described by Newton’s first law. A decrease is observed 
when the signal traveling to the spinal cord is greater than the electrical activity traveling from the spinal 
cord. In contrast, the M-wave will continue to increase as stimulation increases until a plateau is 
observed. At this plateau, all motor units that innervate the muscle have been recruited (Palmieri et al., 
2004; Gajewski et al., 2017). 
Hmax represents the estimated maximum number of motor neurons that can be activated from a 
reflex at a specific time and can be useful in describing an individual’s central fatigue. Mmax represents the 
maximal motor neuron activation and can describe the level of an individual’s peripheral fatigue (Palmieri 
et al., 2004; Gajewski et al., 2017). After the maximum H-wave (Hmax) and Mmax are determined from the 
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recruitment curve, it can be normalized through the use of the Mmax/Hmax ratio, which gives the proportion 
of motor neurons recruited during the reflex to the entire number of motor units in that muscle’s motor 
neuron pool (Palmieri et al., 2004; Gajewski et al., 2017). It can also be used to measure the modifications 
made by the central nervous system (Zhang et al., 2014).  
H-index is used as a diagnostic tool in individuals with peripheral neuropathy. This measurement 
takes into account the onset of the H- and M-wave and the height of the individual and can calculate the 
nerve conduction velocity of the entire reflex arc (Zhang et al., 2014).  
Hoffman’s Reflex and Postural Control 
 Hoffman’s reflex has been used in different populations, positions, and as a dependent variable in 
postural control evaluations and training interventions. An inverse relationship has been suggested in 
healthy adults between postural sway magnitude and H-reflex magnitude, as well as a greater Hmax/Mmax 
ratio with COP displacement in the anterior direction (Chen & Zhou, 2010). Zhang and colleagues (2015) 
investigated the postural control behavior in individuals with peripheral neuropathy. A series of tests, 
such as H-reflex, ankle joint proprioception, TUG, and 6MWD were conducted. It was determined that 
there was a relationship between postural control and H-reflex, as well as a relationship between reduced 
foot sole sensation and 6MWD. This study indicated that individuals with PN have reduced H-reflex.  
 During standing, the H-reflex amplitude is greater in the soleus when compared to the 
gastrocnemius, but the H-/M-ratio is similar between these muscles. Greater muscle activation changes 
the H-reflex. The reaction of H-reflex to muscle activation is evident with the increased amplitude from 
prone to standing, and throughout the gait cycle (Makihara, Segal, Wolpaw, & Thompson, 2011).  
Nardone and colleagues investigated various neuropathies; diabetic neuropathy and Charcot-
Marie-tooth (CMT) disease and evaluated postural control ability under static and dynamic conditions. 
The population consisted of 20 healthy participants (age: 29-77 years), 14 diabetic neuropathy (age: 43-77 
years), and Charcot-Marie-Tooth disease (Type 1: 32-63 years, Type 2: 18-61 years). They reported that 
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diabetic neuropathic individuals were generally unstable during the static quiet stance, but individuals 
with CMT were stable. The difference was evident in the inverse relationship between the increasing 
sway area and decreasing conduction velocity. Researchers concluded that the feedback for the leg 
muscles was type 1a afferent input. 
Hoffman’s Reflex and Postural Control among people with Diabetic Neuropathy 
 When evaluating Hoffman’s reflex and postural control among people with DPN, supplement 
assessments of foot sole sensation and ankle proprioception should be included (Zhang et al., 2014). 
These assessments can give insight on neuroplastic changes that may be occurring within the central 
nervous system. A typical neural adaptation is sensory reweighting. The adaptation occurs when one 
sensory stimulus begins to compensate for a weakened or nonexistent stimulus (Li et al., 2018). It has 
been observed that individuals with PN exhibit decreased H-index, increased postural sway, and impaired 
functional mobility. 
Previous studies have investigated the relationship between DPN and H-reflex. Dixit and 
colleagues were able to determine indirectly that sensory reweighting occurred after eight weeks of 
aerobic training.  Another study conducted by El Bardawil et al. (2013) evaluated the relationship 
between a motor control test of postural responses and electrophysiology of the peripheral nerves. In this 
study, individuals with type 2 diabetes and some with neuropathy were evaluated. It was concluded that 
impaired peripheral nerve function played a role in postural instability. Instability in individuals with 
DPN has thought to be because of PN itself. The effect PN has on postural control instability is evident 
through the central nervous system. For instance, instability may be due to lack of accurate proprioceptive 
feedback, impairment of ankle strength, postural recovery and walking stability in people with diabetes 
(El Bardawil et al., 2013).  
 Based on previous literature, it has been concluded that postural control is impaired in individuals 
with diabetes, peripheral neuropathy, and diabetic neuropathy. The key reason for postural instability in 
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diabetes is muscle weakness, whereas postural instability in neuropathic individuals was due to reduced 
foot sole sensation. When Hoffman’s reflex is included, the neuroplasticity of the central nervous system 
can be investigated. Individuals with diabetes were unstable due to motor deficiency, which leads to no 
change in H-reflex and individuals with neuropathy; however, lead to an enhanced H-reflex.  
Purpose 
Therefore, the purpose of this study is to examine the accumulated effects of diabetic neuropathy 
on neuroplasticity and postural control. It is hypothesized that individuals with DPN will exhibit a greater 
postural sway and decreased H-reflex. The secondary purpose is to examine the influence of ankle joint 
proprioception and reduced foot sole sensation on functional ability and postural performance. It is 
hypothesized that individuals with reduced ankle joint proprioception and reduced foot sole sensation will 
have decreased postural performance and functional ability. The tertiary hypothesis is to determine if a 
relationship between Hoffman’s reflex (i.e H-/M-ratio, H-index) and postural control-related parameters 
(COPsway, COP magnitude, COP velocity) exists. It is hypothesized that individuals with increased 
severity of neuropathy will have a depressed H-reflex and worsened postural control ability.  
Methods 
Participants: 
We will recruit four groups of older adults who are either healthy or physician-diagnosed with 
idiopathic neuropathy, diabetes, or diabetic neuropathy. This study aims to recruit 15 individuals for each 
group. Participants will be recruited from the local community through snowball methods. Participants in 
each of the four groups must be 65 years or older, able to walk unassisted for at least 6 minutes and stand 
for a minimum of 2 minutes.  
Participants will be excluded if they have a history or evidence of central nervous system 
dysfunction, trauma and/or disease that significantly affects their posture and mobility control, evidence 
of foot sole ulcers, evidence of cardiac pacemaker, or answer “yes” to one or more of the follow-up 
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questions on the Physical Activity Readiness Questionnaire plus (PAR-Q+) and do not exercise regularly. 
The Institutional Review Board at Georgia Southern University has approved this project. Prior to data 
collection, signed informed consent would be obtained from each participant after the experimental 
protocol is thoroughly explained and all questions have been satisfactorily answered.  
Experiment Protocol:  
Testing will occur on two different occasions separated by at least 24 hours in the Biomechanics 
Lab. The first session of testing will include the completion of all paperwork and testing cutaneous 
sensitivity, proprioception, leg strength, and functional mobility. Dependent variables are monofilament 
testing score, ankle joint repositioning error, knee peak extensor peak torque, 6-minute walking distance, 
and timed-up-and-go duration.  The second day of testing will include the Hoffman’s reflex (H-reflex) 
test and postural control assessment. H-reflex is a valuable tool in understanding the electrical synaptic 
transmission of the neuromuscular system and can be used to estimate the alpha motor neuron excitability 
in the monosynaptic neural pathway (Palmeiri, Ingersollt, & Hoffman, 2004; Gajewski & Mazur-
Różycka, 2017). Dependent variables are H-/M-wave ratio, H-index, anteroposterior postural sway, 
mediolateral postural sway, postural sway velocity, and entropy. Electrical stimulation can yield a 
maximum M-wave, which is representative of the maximal muscle activation and can describe the level 
of an individual’s peripheral fatigue. Whereas, Hmax represents the estimated maximum number of motor 
neurons that can be activated from a reflex at a given time and can be useful in describing an individual’s 
central fatigue  (Palmeiri et al., 2004; Gajewski et al., 2017).  
On their first visit to the Biomechanics Lab, the participants will be given an overview of the 
research study and have the opportunity to ask any questions. Signatures for the informed consent will be 
obtained before any supplement paperwork is collected, such as the Physical Activity Readiness 
Questionnaire Plus (PAR-Q+), Visual Analogue Score (VAS), Health-Related Quality of Life (SF-36) 
questionnaire, and participant information form. Once the paperwork is completed, anthropometric data 




Cutaneous sensitivity will be assessed using a 5.07-gauge Semmes-Weinstein monofilament 
(North Coast Medical, Inc, Morgan Hill, CA, USA) according to the established protocol (Manor, 
Doherty, & Li, 2008). Testing sites include the heel, midsole, bases of first/fifth metatarsals and hallux. 
This method has been used in this population and has been deemed reliable (Manor, et al., 2008). 
Ankle joint proprioception will be assessed using the Biodex 3 dynamometer (Biodex Medical 
System, Inc, Shirley, NY, USA) and protocol established by Zhang and Li (2014). The participant’s ankle 
will be positioned in the target position of 5 degrees plantarflexion for 10 seconds in which the participant 
will be instructed to close their eyes and concentrate on how their ankle feels. Then the ankle joint will be 
moved to start from the neutral position (i.e., 0 degree) at 1 degree per second toward the targeted 
position. Using the handheld trigger button, participants will stop the motion of the machine when they 
believed their ankle had reached the target position. The error of repositioning will be recorded and the 
test will be repeated three times. The participant will not know the velocity setting for this test. 
Knee joint extensor peak torque will be measured at 60 degrees per second using the Biodex. 
Three repetitions will be performed. Participants will be instructed to exert maximum effort on the third 
repetition. The highest peak torque value will be recorded (Manor et al., 2008). 
A six-minute walk distance test will be used to assess the endurance component of functional 
mobility. Cones will be placed 30 meters apart, as well as taped markers every meter. Participants will be 
instructed to walk at a self-selected pace back and forth for 6 minutes. The verbal cue will be “Three, two, 
one, go,” and the timer will start when the participant initiates movement. The distance covered in 6 
minutes will be recorded to the nearest meter (Manor et al., 2008). 
Timed-up-and-go (TUG) test will be conducted to measure the agility aspect of functional 
mobility. The participant will be begin seated with their back against an armchair. The participant will 
stand up, walk 3 meters, turn around, and walk back 3 meters and sit back down in the armchair. Three 
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meters will be determined from the front edge of the chair, and the timer will start when the participant 
initiates movement and stop when the participant sits against the back of the chair (Manor et al., 2008). A 
total of 3 trials will be conducted and all trials will be used in the analysis. 
Day two of testing will begin with the Hoffman’s reflex test to establish the maximum M- and H- 
wave in the prone and standing position, followed by a postural control assessment. Surface 
electromyography (EMG) electrodes (Trigno Wireless EMG System; Delsys Inc., Massachusetts, USA) 
will be placed on the soleus (Sol), medial gastrocnemius (MG), and lateral gastrocnemius (LG) on the 
declared dominant leg of the participant, and according to SENIAM recommendations. Leg dominance 
will be established using the question, “what foot would you kick a ball with?” Prior to placement, the 
skin will be prepared by wiping the area with alcohol prep pads and shaving the area with a disposable 
razor. After EMG surface electrodes are placed, a 5cm×8cm anode and 2 centimeters (cm) in diameter 
cathode will be placed over the patella and popliteal fossa, respectively.  
To establish the maximum M-wave, the participant will lie in the prone position, and stimulation 
intensity will begin at five microamps (mA) and increase in small increments of 2 mA until 60 mA is 
reached. Stimulation intervals will be separated by 10 seconds. A 500-microsecond square-pulse single 
stimulus delivers the stimulation on the tibial nerve by an electrical nerve stimulator (Digitimer model 
DS7A, Digitimer Ltd., Welwyn Garden City, England).  
The establishment of the maximum M-wave will be repeated in the standing position. The M-/H-
wave ratio and H-index for each position will be used in the analysis. H-index takes into account the 
duration of the onset of the M-wave (TM ) and the H-wave (TH). There will be at least ten minutes of rest 
between tests.  
Postural control will be assessed using an Accusway force plate (AMTI, Watertown, MA, USA). 
Participants will stand with their heels 10 centimeters apart and their feet 10 degrees adducted. Two 30-
second trials of quiet standing eyes open and eyes closed with 45 seconds of rest in between trials will 
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occur (Manor et al., 2008). The testing order will be counterbalanced. The center of pressure will be 
collected at a sampling rate of 1,000 hertz (Hz) using the AMTI Netforce Software. Postural control 
variables will be 95% center of pressure (COP) area, velocity, and entropy in the mediolateral and 
anteroposterior directions. 
Data Analysis:  
 Outcome variables are sensitivity scores, repositioning error scores, knee peak torque scores, total 
distances of 6MW, and TUG durations. From Hoffman’s reflex tests, the dependent variables are MMax-
/HMax-wave ratio and H-index. Maximum M- and H-wave will be determined using peak to peak 
amplitude. H-index = ([𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻ℎ𝑡𝑡 (𝑐𝑐𝑐𝑐)
(𝑇𝑇𝐻𝐻−𝑇𝑇𝑀𝑀)
]2 × 2). Postural control variables are 95% center of pressure (COP) 





, with Ai being the number of matches of length m+1 with its ith template, and Bi as 
the number of matches of length m with ith template. 
Statistical Analysis: 
Statistical analysis will be performed using SPSS 25 (IBM, Armonk, NY). Normality will be 
assessed using Shapiro-Wilks, and skewness and kurtosis. If the p-value from the Shapiro-Wilks test is 
greater than 0.05 the data will be deemed nonparametric. If the p-value is less than 0.05 than the data will 
be deemed parametric. If the ratio between skewness and kurtosis is less than 1.96 the data are parametric. 
If the ratio is greater than 1.96 the data will be deemed nonparametric. 
 Differences for all outcome variables among each group will be assessed using Analysis of 
Variance (ANOVA). A one-way ANOVA will be conducted for parametric data. If the data is 
nonparametric, Friedman’s Two-way ANOVA will be conducted. To compare the effects of peripheral 
neuropathy on the postural control-related variables, an ANCOVA will be conducted using the M-/H-
wave ratio and H-index as covariates. The alpha level will be set at 0.05. Specific group differences will 
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be determined using a Bonferroni post-hoc test if significant ANOVA results were observed. Effects sizes 
will be determined using Cohen’s d. Cohen’s d=�𝑀𝑀1−𝑀𝑀2
𝑆𝑆
�, where S is the standard deviation of the control 
group, M1 is the mean of the control group and M2 is the mean of the experimental group. The criteria for 
the effect size are 0.2<d≤0.5 is small, 0.5<d≤0.8 is medium, and >0.8 will be considered large.  
 To assess the relationship between peripheral neuropathy variables and postural control variables, 
correlation assessments will be conducted. If data are parametric, Pearson’s Product Moment Correlation 
will be calculated; otherwise a Spearman’s Rho correlation will be calculated.  
Expected Results 
 The dependent variables of interest are monofilament testing score, ankle joint repositioning 
error, knee peak extensor peak torque, 6-minute walking distance, timed-up-and-go duration, H-/M-wave 
ratio, H-index, anteroposterior postural sway, mediolateral postural sway, postural sway velocity, and 
entropy. Therefore, the purpose of this study is to examine the accumulated effects of diabetic neuropathy 
on neuroplasticity and postural control. It is hypothesized that individuals with DPN will exhibit a greater 
postural sway and decreased H-reflex. I expect to see an increase in anterior-posterior COP sway in all 
participants (Laughton et al., 2002; Eftekhar-Sadat et al., 2015). Since diabetes does not affect H-reflex, 
but PN does. I expect to see a decreased H-reflex when compared to the PN group. The secondary 
purpose is to examine the influence of ankle joint proprioception, leg strength and foot sole sensation on 
functional ability and postural control performance. It is hypothesized that individuals with reduced ankle 
joint proprioception and reduced foot sole sensation will have decreased postural control performance and 
functional ability. For individuals who have greater sway in the mediolateral direction, they will exhibit 
reduced foot sole sensation, and ankle joint proprioception (Bonnet & Lepeut, 2011). The tertiary 
hypothesis is to determine if a relationship between Hoffman’s reflex (i.e., H-/M-ratio, H-index) and 
postural control parameters (COP sway, COP magnitude, COP velocity) exists. It is expected that there will 
a greater H-/M-ratio when compared to COP displacement (Chen & Zhou, 2010). Then individuals with 
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more severe neuropathy, evident by reduced foot sole sensation and ankle joint proprioception, decreased 
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APPENDICES B: STATISTICAL OUTPUT 
GET 
  FILE="C:\Users\kl06040\Desktop\Master's Thesis\Thesis\Thesis\Real Data Collection\DATA 
ANALYSIS\SPSS\PN_Data 10 variables_1.sav". 
DATASET NAME DataSet1 WINDOW=FRONT. 
GLM @6MWDM TUGSEC SDycmEO VavgcmsEO BY Code 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /POSTHOC=Code(LSD) 
  /EMMEANS=TABLES(Code) COMPARE ADJ(LSD) 
  /PRINT=DESCRIPTIVE ETASQ 
  /CRITERIA=ALPHA(.05) 
  /DESIGN= Code. 
 
General Linear Model 
 
Notes 








Active Dataset DataSet1 
Filter <none> 
Weight <none> 
Split File <none> 
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N of Rows in Working Data 
File 
35 
Missing Value Handling Definition of Missing User-defined missing values 
are treated as missing. 
Cases Used Statistics are based on all 
cases with valid data for all 
variables in the model. 
Syntax GLM @6MWDM TUGSEC 
SDycmEO VavgcmsEO BY 
Code 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 




  /PRINT=DESCRIPTIVE 
ETASQ 
  /CRITERIA=ALPHA(.05) 
  /DESIGN= Code. 
Resources Processor Time 00:00:00.02 
Elapsed Time 00:00:00.03 
 
[DataSet1] C:\Users\kl06040\Desktop\Master's Thesis\Thesis\Thesis\Real Data Collection\DATA 












 Code Mean Std. Deviation N 
6MWD (M) 1.00 450.1000 52.15458 10 
2.00 440.1667 60.70320 12 
3.00 401.6923 67.25621 13 
Total 428.7143 62.99747 35 
TUG (SEC) 1.00 7.3600 1.26069 10 
2.00 8.1000 2.03157 12 
3.00 8.6308 1.40913 13 
Total 8.0857 1.65087 35 
SDy (cm) EO 1.00 .4210 .16941 10 
2.00 .4183 .14868 12 
3.00 .4615 .10164 13 
Total .4351 .13719 35 
Vavg (cm/s) EO 1.00 17.6540 4.36141 10 
2.00 15.3508 3.70299 12 
3.00 12.6531 2.99480 13 
Total 15.0069 4.10586 35 
 
Multivariate Testsa 
Effect Value F Hypothesis df Error df Sig. 
Intercept Pillai's Trace .997 2248.216b 4.000 29.000 .000 
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Wilks' Lambda .003 2248.216b 4.000 29.000 .000 
Hotelling's Trace 310.099 2248.216b 4.000 29.000 .000 
Roy's Largest Root 310.099 2248.216b 4.000 29.000 .000 
Code Pillai's Trace .380 1.760 8.000 60.000 .103 
Wilks' Lambda .635 1.845b 8.000 58.000 .087 
Hotelling's Trace .549 1.922 8.000 56.000 .075 
Roy's Largest Root .500 3.752c 4.000 30.000 .014 
 
Multivariate Testsa 
Effect Partial Eta Squared 
Intercept Pillai's Trace .997 
Wilks' Lambda .997 
Hotelling's Trace .997 
Roy's Largest Root .997 
Code Pillai's Trace .190 
Wilks' Lambda .203 
Hotelling's Trace .215 
Roy's Largest Root .333 
 
a. Design: Intercept + Code 
b. Exact statistic 
c. The statistic is an upper bound on F that yields a lower bound on the significance level. 
 
Tests of Between-Subjects Effects 
Source Dependent Variable 
Type III Sum of 
Squares df Mean Square F 
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Corrected Model 6MWD (M) 15639.807a 2 7819.903 2.098 
TUG (SEC) 9.131b 2 4.566 1.749 
SDy (cm) EO .014c 2 .007 .370 
Vavg (cm/s) EO 143.517d 2 71.759 5.344 
Intercept 6MWD (M) 6413513.465 1 6413513.465 1720.373 
TUG (SEC) 2229.975 1 2229.975 854.277 
SDy (cm) EO 6.502 1 6.502 332.691 
Vavg (cm/s) EO 8009.965 1 8009.965 596.566 
Code 6MWD (M) 15639.807 2 7819.903 2.098 
TUG (SEC) 9.131 2 4.566 1.749 
SDy (cm) EO .014 2 .007 .370 
Vavg (cm/s) EO 143.517 2 71.759 5.344 
Error 6MWD (M) 119295.336 32 3727.979  
TUG (SEC) 83.532 32 2.610  
SDy (cm) EO .625 32 .020  
Vavg (cm/s) EO 429.657 32 13.427  
Total 6MWD (M) 6567793.000 35   
TUG (SEC) 2380.920 35   
SDy (cm) EO 7.267 35   
Vavg (cm/s) EO 8455.376 35   
Corrected Total 6MWD (M) 134935.143 34   
TUG (SEC) 92.663 34   
SDy (cm) EO .640 34   
Vavg (cm/s) EO 573.174 34   
 
Tests of Between-Subjects Effects 
61 
 
Source Dependent Variable Sig. Partial Eta Squared 
Corrected Model 6MWD (M) .139 .116 
TUG (SEC) .190 .099 
SDy (cm) EO .694 .023 
Vavg (cm/s) EO .010 .250 
Intercept 6MWD (M) .000 .982 
TUG (SEC) .000 .964 
SDy (cm) EO .000 .912 
Vavg (cm/s) EO .000 .949 
Code 6MWD (M) .139 .116 
TUG (SEC) .190 .099 
SDy (cm) EO .694 .023 
Vavg (cm/s) EO .010 .250 
Error 6MWD (M)   
TUG (SEC)   
SDy (cm) EO   
Vavg (cm/s) EO   
Total 6MWD (M)   
TUG (SEC)   
SDy (cm) EO   
Vavg (cm/s) EO   
Corrected Total 6MWD (M)   
TUG (SEC)   
SDy (cm) EO   




a. R Squared = .116 (Adjusted R Squared = .061) 
b. R Squared = .099 (Adjusted R Squared = .042) 
c. R Squared = .023 (Adjusted R Squared = -.039) 
d. R Squared = .250 (Adjusted R Squared = .204) 
 





Dependent Variable Code Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
6MWD (M) 1.00 450.100 19.308 410.771 489.429 
2.00 440.167 17.626 404.264 476.069 
3.00 401.692 16.934 367.198 436.186 
TUG (SEC) 1.00 7.360 .511 6.319 8.401 
2.00 8.100 .466 7.150 9.050 
3.00 8.631 .448 7.718 9.544 
SDy (cm) EO 1.00 .421 .044 .331 .511 
2.00 .418 .040 .336 .501 
3.00 .462 .039 .383 .541 
Vavg (cm/s) EO 1.00 17.654 1.159 15.294 20.014 
2.00 15.351 1.058 13.196 17.505 






Dependent Variable (I) Code (J) Code 
Mean Difference 





6MWD (M) 1.00 2.00 9.933 26.143 .706 -43.318 
3.00 48.408 25.682 .069 -3.905 
2.00 1.00 -9.933 26.143 .706 -63.185 
3.00 38.474 24.442 .125 -11.313 
3.00 1.00 -48.408 25.682 .069 -100.720 
2.00 -38.474 24.442 .125 -88.262 
TUG (SEC) 1.00 2.00 -.740 .692 .293 -2.149 
3.00 -1.271 .680 .071 -2.655 
2.00 1.00 .740 .692 .293 -.669 
3.00 -.531 .647 .418 -1.848 
3.00 1.00 1.271 .680 .071 -.113 
2.00 .531 .647 .418 -.787 
SDy (cm) EO 1.00 2.00 .003 .060 .965 -.119 
3.00 -.041 .059 .496 -.160 
2.00 1.00 -.003 .060 .965 -.125 
3.00 -.043 .056 .446 -.157 
3.00 1.00 .041 .059 .496 -.079 
2.00 .043 .056 .446 -.071 
Vavg (cm/s) EO 1.00 2.00 2.303 1.569 .152 -.893 
3.00 5.001* 1.541 .003 1.861 
2.00 1.00 -2.303 1.569 .152 -5.499 
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3.00 2.698 1.467 .075 -.290 
3.00 1.00 -5.001* 1.541 .003 -8.140 
2.00 -2.698 1.467 .075 -5.686 
 
Pairwise Comparisons 
Dependent Variable (I) Code (J) Code 
95% Confidence Interval for 
Difference 
Upper Bound 
6MWD (M) 1.00 2.00 63.185 
3.00 100.720 
2.00 1.00 43.318 
3.00 88.262 
3.00 1.00 3.905 
2.00 11.313 
TUG (SEC) 1.00 2.00 .669 
3.00 .113 
2.00 1.00 2.149 
3.00 .787 
3.00 1.00 2.655 
2.00 1.848 
SDy (cm) EO 1.00 2.00 .125 
3.00 .079 
2.00 1.00 .119 
3.00 .071 




Vavg (cm/s) EO 1.00 2.00 5.499 
3.00 8.140 
2.00 1.00 .893 
3.00 5.686 
3.00 1.00 -1.861 
2.00 .290 
 
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Least Significant Difference (equivalent to no adjustments). 
 
Multivariate Tests 
 Value F Hypothesis df Error df Sig. 
Partial Eta 
Squared 
Pillai's trace .380 1.760 8.000 60.000 .103 .190 
Wilks' lambda .635 1.845a 8.000 58.000 .087 .203 
Hotelling's trace .549 1.922 8.000 56.000 .075 .215 
Roy's largest root .500 3.752b 4.000 30.000 .014 .333 
 
Each F tests the multivariate effect of Code . These tests are based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
a. Exact statistic 





Squares df Mean Square F Sig. 
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6MWD (M) Contrast 15639.807 2 7819.903 2.098 .139 
Error 119295.336 32 3727.979   
TUG (SEC) Contrast 9.131 2 4.566 1.749 .190 
Error 83.532 32 2.610   
SDy (cm) EO Contrast .014 2 .007 .370 .694 
Error .625 32 .020   
Vavg (cm/s) EO Contrast 143.517 2 71.759 5.344 .010 
Error 429.657 32 13.427   
Univariate Tests 
Dependent Variable Partial Eta Squared 
6MWD (M) Contrast .116 
Error  
TUG (SEC) Contrast .099 
Error  
SDy (cm) EO Contrast .023 
Error  
Vavg (cm/s) EO Contrast .250 
Error  
 
The F tests the effect of Code . This test is based on the linearly independent pairwise comparisons among the 
estimated marginal means. 
 







LSD   
Dependent Variable (I) Code (J) Code 
Mean Difference 





6MWD (M) 1.00 2.00 9.9333 26.14312 .706 -43.3185 
3.00 48.4077 25.68201 .069 -3.9048 
2.00 1.00 -9.9333 26.14312 .706 -63.1851 
3.00 38.4744 24.44243 .125 -11.3132 
3.00 1.00 -48.4077 25.68201 .069 -100.7202 
2.00 -38.4744 24.44243 .125 -88.2620 
TUG (SEC) 1.00 2.00 -.7400 .69179 .293 -2.1491 
3.00 -1.2708 .67958 .071 -2.6550 
2.00 1.00 .7400 .69179 .293 -.6691 
3.00 -.5308 .64678 .418 -1.8482 
3.00 1.00 1.2708 .67958 .071 -.1135 
2.00 .5308 .64678 .418 -.7867 
SDy (cm) EO 1.00 2.00 .0027 .05986 .965 -.1193 
3.00 -.0405 .05880 .496 -.1603 
2.00 1.00 -.0027 .05986 .965 -.1246 
3.00 -.0432 .05597 .446 -.1572 
3.00 1.00 .0405 .05880 .496 -.0792 
2.00 .0432 .05597 .446 -.0708 
Vavg (cm/s) EO 1.00 2.00 2.3032 1.56894 .152 -.8927 
3.00 5.0009* 1.54127 .003 1.8615 
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2.00 1.00 -2.3032 1.56894 .152 -5.4990 
3.00 2.6978 1.46688 .075 -.2902 
3.00 1.00 -5.0009* 1.54127 .003 -8.1404 
2.00 -2.6978 1.46688 .075 -5.6857 
 
Multiple Comparisons 
LSD   
Dependent Variable (I) Code (J) Code 
95% Confidence Interval 
Upper Bound 
6MWD (M) 1.00 2.00 63.1851 
3.00 100.7202 
2.00 1.00 43.3185 
3.00 88.2620 
3.00 1.00 3.9048 
2.00 11.3132 
TUG (SEC) 1.00 2.00 .6691 
3.00 .1135 
2.00 1.00 2.1491 
3.00 .7867 
3.00 1.00 2.6550 
2.00 1.8482 
SDy (cm) EO 1.00 2.00 .1246 
3.00 .0792 
2.00 1.00 .1193 
3.00 .0708 




Vavg (cm/s) EO 1.00 2.00 5.4990 
3.00 8.1404 
2.00 1.00 .8927 
3.00 5.6857 
3.00 1.00 -1.8615 
2.00 .2902 
 
Based on observed means. 
 The error term is Mean Square(Error) = 13.427. 
*. The mean difference is significant at the .05 level. 
 
DISCRIMINANT 
  /GROUPS=Code(1 3) 
  /VARIABLES=@6MWDM TUGSEC SDycmEO VavgcmsEO 
  /ANALYSIS ALL 
  /METHOD=WILKS 
  /FIN=0.05 
  /FOUT=0.01 
  /PRIORS EQUAL 
  /HISTORY 
  /STATISTICS=MEAN STDDEV CORR TABLE CROSSVALID 
  /PLOT=COMBINED 















Active Dataset DataSet1 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in Working Data 
File 
35 
Missing Value Handling Definition of Missing User-defined missing values 
are treated as missing in the 
analysis phase. 
Cases Used In the analysis phase, cases 
with no user- or system-
missing values for any 
predictor variable are used. 
Cases with user-, system-
missing, or out-of-range 
values for the grouping 




  /GROUPS=Code(1 3) 
  /VARIABLES=@6MWDM 
TUGSEC SDycmEO 
VavgcmsEO 
  /ANALYSIS ALL 
  /METHOD=WILKS 
  /FIN=0.05 
  /FOUT=0.01 
  /PRIORS EQUAL 
  /HISTORY 
  /STATISTICS=MEAN 
STDDEV CORR TABLE 
CROSSVALID 
  /PLOT=COMBINED 
  /CLASSIFY=NONMISSING 
POOLED. 
Resources Processor Time 00:00:02.47 
Elapsed Time 00:00:01.05 
 
Analysis Case Processing Summary 
Unweighted Cases N Percent 
Valid 35 100.0 
Excluded Missing or out-of-range group 
codes 
0 .0 





Both missing or out-of-range 




Total 0 .0 
Total 35 100.0 
 
Group Statistics 
Code Mean Std. Deviation 
Valid N (listwise) 
Unweighted Weighted 
1.00 6MWD (M) 450.1000 52.15458 10 10.000 
TUG (SEC) 7.3600 1.26069 10 10.000 
SDy (cm) EO .4210 .16941 10 10.000 
Vavg (cm/s) EO 17.6540 4.36141 10 10.000 
2.00 6MWD (M) 440.1667 60.70320 12 12.000 
TUG (SEC) 8.1000 2.03157 12 12.000 
SDy (cm) EO .4183 .14868 12 12.000 
Vavg (cm/s) EO 15.3508 3.70299 12 12.000 
3.00 6MWD (M) 401.6923 67.25621 13 13.000 
TUG (SEC) 8.6308 1.40913 13 13.000 
SDy (cm) EO .4615 .10164 13 13.000 
Vavg (cm/s) EO 12.6531 2.99480 13 13.000 
Total 6MWD (M) 428.7143 62.99747 35 35.000 
TUG (SEC) 8.0857 1.65087 35 35.000 
SDy (cm) EO .4351 .13719 35 35.000 




Pooled Within-Groups Matrices 
 6MWD (M) TUG (SEC) SDy (cm) EO Vavg (cm/s) EO 
Correlation 6MWD (M) 1.000 -.721 .033 -.075 
TUG (SEC) -.721 1.000 .066 .050 
SDy (cm) EO .033 .066 1.000 -.208 









Statistic df1 df2 df3 
Exact F 
Statistic df1 df2 
1 Vavg (cm/s) EO .750 1 2 32.000 5.344 2 32.000 
2 6MWD (M) .666 2 2 32.000 3.491 4 62.000 
3 TUG (SEC) .642 3 2 32.000 2.482 6 60.000 














At each step, the variable that minimizes the overall Wilks' Lambda is entered.a,b,c,d 
a. Maximum number of steps is 8. 
b. Minimum partial F to enter is 0.05. 
c. Maximum partial F to remove is 0.01. 
d. F level, tolerance, or VIN insufficient for further computation. 
 
Variables in the Analysis 
Step Tolerance F to Remove Wilks' Lambda 
1 Vavg (cm/s) EO 1.000 5.344  
2 Vavg (cm/s) EO .994 5.072 .884 
6MWD (M) .994 1.942 .750 
3 Vavg (cm/s) EO .994 4.843 .849 
6MWD (M) .479 .964 .683 
TUG (SEC) .481 .568 .666 
4 Vavg (cm/s) EO .952 4.409 .829 
6MWD (M) .474 .983 .679 
TUG (SEC) .473 .604 .662 
SDy (cm) EO .940 .145 .642 
 
Variables Not in the Analysis 
Step Tolerance Min. Tolerance F to Enter Wilks' Lambda 
0 6MWD (M) 1.000 1.000 2.098 .884 
TUG (SEC) 1.000 1.000 1.749 .901 
75 
 
SDy (cm) EO 1.000 1.000 .370 .977 
Vavg (cm/s) EO 1.000 1.000 5.344 .750 
1 6MWD (M) .994 .994 1.942 .666 
TUG (SEC) .998 .998 1.510 .683 
SDy (cm) EO .957 .957 .093 .745 
2 TUG (SEC) .481 .479 .568 .642 
SDy (cm) EO .957 .952 .094 .662 





Variables Lambda df1 df2 df3 
Exact F 
Statistic df1 df2 
1 1 .750 1 2 32 5.344 2 32.000 
2 2 .666 2 2 32 3.491 4 62.000 
3 3 .642 3 2 32 2.482 6 60.000 
















Function Eigenvalue % of Variance Cumulative % 
Canonical 
Correlation 
1 .500a 91.1 91.1 .577 
2 .049a 8.9 100.0 .216 
 
a. First 2 canonical discriminant functions were used in the analysis. 
 
Wilks' Lambda 
Test of Function(s) Wilks' Lambda Chi-square df Sig. 
1 through 2 .635 13.828 8 .086 








6MWD (M) .420 1.270 
TUG (SEC) -.198 1.240 
SDy (cm) EO -.015 -.474 








Vavg (cm/s) EO .816* -.124 
6MWD (M) .498* .376 
TUG (SEC) -.459* .284 
SDy (cm) EO -.192 -.311* 
 
Pooled within-groups correlations between 
discriminating variables and standardized 
canonical discriminant functions  
 Variables ordered by absolute size of 
correlation within function. 
*. Largest absolute correlation between each 
variable and any discriminant function 
 





1.00 .854 -.201 
2.00 .159 .288 
3.00 -.804 -.112 
 
Unstandardized canonical 









Excluded Missing or out-of-range group 
codes 
0 
At least one missing 
discriminating variable 
0 
Used in Output 35 
 
Prior Probabilities for Groups 
Code Prior 
Cases Used in Analysis 
Unweighted Weighted 
1.00 .333 10 10.000 
2.00 .333 12 12.000 
3.00 .333 13 13.000 









Predicted Group Membership 
Total 1.00 2.00 3.00 
Original Count 1.00 5 4 1 10 
2.00 2 6 4 12 
3.00 1 4 8 13 
% 1.00 50.0 40.0 10.0 100.0 
2.00 16.7 50.0 33.3 100.0 
3.00 7.7 30.8 61.5 100.0 
Cross-validatedb Count 1.00 3 6 1 10 
2.00 5 3 4 12 
3.00 2 4 7 13 
% 1.00 30.0 60.0 10.0 100.0 
2.00 41.7 25.0 33.3 100.0 
3.00 15.4 30.8 53.8 100.0 
 
a. 54.3% of original grouped cases correctly classified. 
b. Cross validation is done only for those cases in the analysis. In cross validation, each 
case is classified by the functions derived from all cases other than that case. 
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